The CFP10/ESAT6 complex of Mycobacterium tuberculosis may function as a regulator of macrophage cell death at different stages of tuberculosis infection

Medical Hypotheses

Volumn 78, Issue 3, 2012, Pages 389-392

  Guo, Si ^a   Xue, Rui ^b   Li, Yi ^a   Wang, Shan Mei ^a   Ren, Lin ^a   Xu, Jing Jing ^b  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; SECRETORY ANTIGENIC TARGET PROTEIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CELL DEATH; GENOMICS; IMMUNOGENICITY; LUNG ALVEOLUS MACROPHAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRULENCE;

ANTIGENS, BACTERIAL; APOPTOSIS; BACTERIAL PROTEINS; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 84856496111     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.11.022     Document Type: Article

References (47)

1. Dye C., Scheel S., Dolin P., Pathania V., Raviglion M.C. Consensus statement. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 1999, 282:677-686.
2. Raviglione M.C., Dye C., Schmidt S., Kochi A. Assessment of worldwide tuberculosis control. WHO global surveillance and monitoring project. Lancet 1997, 350:624-629.
3. Riendeau C.J., Kornfeld H. THP-1 cell apoptosis in response to mycobacterium infection. Infect Immun 2003, 71:254-259.
4. Sly L.M., Hingley-Wilson S.M., Reiner N.E., McMaster W.R. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol 2003, 170:430-437.
5. Schaible U.E., Winau F., Sieling P.A., et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003, 9:1039-1046.
6. Keane J., Remold H.G., Kornfled H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophage. J Immunol 2000, 164:2016-2020.
7. Dhiman R., Raje M., Majumdar S. Differential expression of NF-kappa B in mycobacteria infected THP-1 affects apoptosis. Biochim Biophys Acta 2007, 1770:649-658.
8. Zhang J., Jiang R., Takayama H., Tanaka Y. Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol Immunol 2005, 49:845-852.
9. Behr M.A., Wilson M.A., Gill W.P., et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999, 284:1520-1523.
10. Behar S.M., Dascher C.C., Grusby M.J., Wang C.R., Brenner M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med 1999, 189:1973-1980.
11. Renshaw P.S., Panagiotidou P., Whelan A., et al. Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6-CFP-10 complex: implications for pathogenesis and virulence. J Biol Chem 2002, 277:21598-21603.
12. Pym A.S., Brodin P., Brosch R., Huerre M., Cole S.T. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002, 46:709-717.
13. Lewis K.N., Liao R., Guinn K.M., et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacilli Calmette-Guérin attenuation. J Infect Dis 2003, 187:117-123.
14. Pym A.S., Brodin P., Majlessi L., et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9:533-539.
15. Wards B.J., Lisle G.W.D., Collins D.M. An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuberc Lung Dis 2000, 80:185-189.
16. Pathak S.K., Basu S., Basu K.K., et al. Direct extracellular interaction between the early secreted antigen ESAT-6 of mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 2007, 8:610-618.
17. Stanely S., Raghavan S., Hwang W.W., Cox J.S. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci 2003, 100:13001-13006.
18. Trajkovic G., Singh G., Singh B., et al. Effect of Mycobacterium tuberculosis 10-Kilodalton antigen on macrophage release of tumor necrosis factor alpha and nitric oxide. Infect Immun 2002, 70:6558-6566.
19. Feng Y., Yang X., Liu Z., et al. Continuous treatment with recombinant Mycobacterium tuberculosis CFP-10-ESAT-6 protein activated human monocyte while deactivated LPS-stimulated macrophage. Biochem Biophys Res Commun 2008, 365:534-540.
20. Si G., Lang B., Zi Fang Q., Xin Xin S. The CFP10/ESAT6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-γ signaling. Med Microbiol Immunol 2010, 991:129-137.
21. Kindler V., Sappino A.P., Grau G.E., Piguet P.F., Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989, 56(5):731-740.
22. Keane J., Balcewicz-Sablinska K., Remold H.G., et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997, 65:298-304.
23. Molloy A., Laochumroonvorapong P., Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med 1994, 180:1499-1509.
24. Fratazzi C., Arbeit R.D., Carini C., Remold H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J Immunol 1997, 158:4320-4327.
25. Keane J., Shurtleff B., Kornfeld H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) 2002, 82:55-61.
26. Beltan E., Horgen L., Rastogi N. Secretion of cytokines by human macrophages upon infection by pathogenic and non-pathogenic mycobacteria. Microb Pathog 2000, 28(5):313-318.
27. Demissie A., Abebe M., Aseffa A., et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis expression high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 2004, 172:6938-6943.
28. Demissie A., Wassie L., Abebe M., et al. The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients expression elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect Immun 2006, 74:2817-2822.
29. Fletcher H.A., Owiafe P., Jeffries D., et al. Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology 2004, 112:669-673.
30. Abebe M, Kim L, Rook G et al. Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clin Dev Immunol 2011; doi:10.1155/2011/678570.
31. Filley E.A., Bull H.A., Dowd P.M., Rook G.A.W. The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumor necrosis factor. Immunology 1992, 77:505-509.
32. Filley E.A., Rook G.A. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Immunology 1991, 59:2567-2572.
33. Klimpel G.R., Shaban R., Niesel D.W. Bacteria-infected fibroblasts have enhanced susceptibility to the cytotoxic action of tumor necrosis factor. J Immunol 1990, 145:711-717.
34. Flynn J.L., Goldstein M.M., Chan J., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2(6):561-572.
35. Jacobs M., Brown N., Allie N., Ryffel B. Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin Immunol 2000, 94(3):192-199.
36. Bekker L.G., Moreira A.L., Bergtold A., Ryffel B., Kaplan G. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect Immun 2000, 68(12):6954-6961.
37. Ehlers S., Benini J., Held H.D., Roeck C., Alber G., Uhlig S. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model for mycobacteria-induced pulmonary immunopathology. J Exp Med 2001, 194(12):1847-1859.
38. Bezuidenhout J., Roberts T., Muller L., et al. Pleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas. PLoS One 2009, 4:e4228.
39. Byrd T.F. Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNF alpha from iron-treated infected monocytes. J Clin Invest 1997, 99(10):2518-2529.
40. Engele M., Stossel E., Castiglione K., Schwerdtner N., Wagner M., Bolcskei P., et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis. J Immunol 2002, 168(3):1328-1337.
41. Miyairi I., Byrne G.I. Chlamydia and programmed cell death. Curr Opin Microbiol 2006, 9:102-108.
42. Losick V.P., Isberg R.R. NF- kappa B translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp Med 2006, 203:2177-2189.
43. Santic M., Asare R., Doric M., et al. Host-dependent trigger of caspases and apoptosis by Legionella pneumophila. Infect Immun 2007, 75:2903-2913.
44. Lee J., Remold H.G., Ieong M.H., et al. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 2006, 176:4267-4274.
45. O'Sullivan M.P., O'Leary S., Kelly D.M., et al. A caspase-independent pathway mediates macrophage cell death in response to Mycobacterium tuberculosis infection. Infect Immun 2007, 75:1984-1993.
46. Pan H., Yan B.S., Rojas M., et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005, 434:767-772.
47. Renshaw P.S., Lightbody K.L., Veverka V., et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP10 and ESAT-6. J EMBO 2005, 24:2491-2498.